Gentamicin sulfate - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for gentamicin sulfate and what is the scope of freedom to operate?

Gentamicin sulfate is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, King Pharms, Bristol, Intl Medication, Abbott, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Fera Pharms Llc, Sciegen Pharms Inc, Encube, Allergan, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Paco, and Sandoz, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for gentamicin sulfate. Twenty-seven suppliers are listed for this compound.

Summary for gentamicin sulfate

US Patents:	0
Tradenames:	12
Applicants:	35
NDAs:	62
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	27
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	13
Patent Applications:	626
What excipients (inactive ingredients) are in gentamicin sulfate?	gentamicin sulfate excipients list
DailyMed Link:	gentamicin sulfate at DailyMed

Drug Sales Revenue Trends for gentamicin sulfate

See drug sales revenues for gentamicin sulfate

Recent Clinical Trials for gentamicin sulfate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Oslo University Hospital	Phase 1/Phase 2
University of California, San Diego	Phase 2
Kaiser Permanente	Phase 2

See all gentamicin sulfate clinical trials

Pharmacology for gentamicin sulfate

Drug Class	Aminoglycoside Antibacterial

Anatomical Therapeutic Chemical (ATC) Classes for gentamicin sulfate

US Patents and Regulatory Information for gentamicin sulfate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms	APOGEN	gentamicin sulfate	INJECTABLE;INJECTION	062289-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	gentamicin sulfate	INJECTABLE;INJECTION	062414-002	Aug 15, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Solopak	GENTAMICIN SULFATE	gentamicin sulfate	INJECTABLE;INJECTION	062507-002	Jun 6, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	gentamicin sulfate	INJECTABLE;INJECTION	062414-009	Aug 15, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Solopak	GENTAMICIN SULFATE	gentamicin sulfate	INJECTABLE;INJECTION	062507-001	Jun 6, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
B Braun	GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	gentamicin sulfate	INJECTABLE;INJECTION	062814-005	Aug 28, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms	APOGEN	gentamicin sulfate	INJECTABLE;INJECTION	062289-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.